- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Crude Drug.
Displaying page 1 of 1.
EudraCT Number: 2020-001531-27 | Sponsor Protocol Number: SARICOR | Start Date*: 2020-04-18 | ||||||||||||||||
Sponsor Name:Fundación para la Investigación Biomédica de Córdoba | ||||||||||||||||||
Full Title: Clinical trial of Sarilumab in adults hospitalized with COVID-19 presenting cytokine release syndrome | ||||||||||||||||||
Medical condition: SARS-CoV-2 infection causing respiratory disease and cytokine release syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002796-10 | Sponsor Protocol Number: PROMELUNG | Start Date*: 2017-02-03 |
Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut MAR) | ||
Full Title: Assessment of intrapulmonary concentrations of meropenem administered by continuous infusion in postoperative pneumonia. | ||
Medical condition: Post-operative pneumonia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002255-15 | Sponsor Protocol Number: ST3073-ST3074-DM-12-002 | Start Date*: 2014-11-04 |
Sponsor Name:Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | ||
Full Title: A phase II, open-label, multicentre, pharmacokinetic, pharmacodynamics and safety study of a new paediatric eurartesim dispersible formulation and crushed film coated eurartesim tablet, in infant p... | ||
Medical condition: Uncomplicated Plasmodium falciparum malaria | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2010-020226-17 | Sponsor Protocol Number: CRO 1644 | Start Date*: 2010-12-23 | |||||||||||
Sponsor Name:Imperial College | |||||||||||||
Full Title: An evaluation of the effect of an angiotensin-converting enzyme (ACE) inhibitor on the growth rate of small abdominal aortic aneurysms | |||||||||||||
Medical condition: Abdominal Aortic Aneurysms | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005979-12 | Sponsor Protocol Number: XT-2002 | Start Date*: 2021-07-26 | |||||||||||
Sponsor Name:XENOTHERA | |||||||||||||
Full Title: An international, placebo-controlled, double-blind, randomized clinical trial to evaluate the efficacy and safety of 150 mg XAV-19 infusion, in patients with moderate to severe COVID-19: the EUROXA... | |||||||||||||
Medical condition: Moderate to severe COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) GR (Prematurely Ended) BG (Prematurely Ended) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004970-16 | Sponsor Protocol Number: CS15-033 | Start Date*: 2017-05-30 | |||||||||||
Sponsor Name:Medizinische Universität Wien | |||||||||||||
Full Title: Imaging the functional and molecular impact of poly-unsaturated fatty acids on dopamine-dependent cognitive functions: a combined [11C]-(+)-PHNO PET/MRI study at different stages of cognitive impai... | |||||||||||||
Medical condition: This study will assess the effects of poly-unsaturated fatty acids on working memory (measured using an n-back test) in healthy volunteers, in subjects who are at high risk for developing a psychot... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003798-16 | Sponsor Protocol Number: 372-07 | Start Date*: 2008-10-13 |
Sponsor Name:Cardiff University | ||
Full Title: AML 17: A Programme of Treatment Development in Younger Patients with Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome | ||
Medical condition: Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) DK (Completed) IE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.